By Chadi Nabhan, MD, MBA, FACP - Last Updated: February 8, 2023
In the latest episode of The HemOnc Pulse, Laurie H. Sehn, MD, MPH, Chair of the Lymphoma Tumour Group at the BC Cancer Centre for Lymphoid Cancer and Associate Editor of Blood Cancers Today, talks with host Chadi Nabhan, MD, MBA, FACP, about which bispecific antibodies will change the game in follicular lymphoma treatment. Dr. Sehn also explains why the TRIANGLE study is anticipated to be practice-changing and how it may make upfront transplant obsolete in mantle cell lymphoma.
Listen to the episode HERE.
Original Source: Laurie H. Sehn, MD, MPH, on the Game-Changing Bispecifics in Follicular Lymphoma | Blood Cancers Today